StockMarketWire.com - Advanced materials company Directa Plus said its graphene material could be used in medical devices to help Italian authorities combat the Covid-19 pandemic.
The company confirmed its Italian operations were unaffected by government moves to close down activity not associated with essential goods and services.
Directa Plus was classified as a chemical company in Italy and as such was exempt from any restrictions. The company said its graphene was non-toxic and its bacteriostatic properties could be used in the production of medical devices, such as masks, gloves and gowns to ensure better prevention properties for the spread of the virus.
'Medical equipment enhanced by graphene could mean a safer working environment for the health workers and all citizens,' chief executive Giulio Cesareo said.
'In the health industry graphene is well known for antibacterial and filtering properties and we will continue to develop protective devices using our non-toxic G+ graphene to benefit our fellow citizens during this emergency.'
At 2:46pm: [LON:DCTA] Directa Plus Plc share price was -2p at 49p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.